Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05364489	Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer	not yet recruiting	Phase 2	20	The First Affiliated Hospital of Zhengzhou UniversityOTHER	0	May 20, 2022	clinicaltrials
NCT05239650	Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC	not yet recruiting	Phase 2	50	Shanghai Henlius BiotechINDUSTRY	0